NCT06978725
- Conditions
- Cutaneous Sarcoidosis, Hemic and Lymphatic Diseases, Hypersensitivity, +5 more
- Locations
-
- Clinical Trial Site San Francisco, California, United States
- Clinical Trial Site Durham, North Carolina, United States
- Clinical Trial Site Philadelphia, Pennsylvania, United States
- Clinical Trial Site Madison, Wisconsin, United States